What is TG Therapeutics's investment proceeds?

TG Therapeutics (TGTX) reported investment proceeds of $11.25M in Q1 2026.

How has TG Therapeutics's investment proceeds changed year-over-year?

TG Therapeutics's investment proceeds decreased by 86.0% year-over-year, from $80.4M to $11.25M.

What is the long-term trend for TG Therapeutics's investment proceeds?

Over 3 years (2021 to 2025), TG Therapeutics's investment proceeds has grown at a 62.3% compound annual growth rate (CAGR), from $55.6M to $237.5M.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

TG Therapeutics TGTX Investment Proceeds

Investment Proceeds at other companies

BiogenBIIB

$500K—

BridgeBio PharmaBBIO

$10M—

Krystal Biotech, Inc.KRYS

$103.6M+16.7%

Arrowhead ResearchARWR

$115.34M-2.4%

Rhythm Pharmaceuticals, Inc.RYTM

$99.25M+70.1%

Mirum Pharmaceuticals, Inc.MIRM

$33.89M+94.4%

Other financials

Income statement

See full

Revenue$204.9M+69.6%

Gross profit$171.4M+62.8%

Operating income$34.8M+304%

Net income$19.8M+291%

EPS (diluted)$0.12+300%

Balance sheet

See full

Cash & equivalents$442.2M+235%

Total debt$753.6M+197%

Total equity$583.1M+146%

Total assets$1.5B+133%

Cash flow

See full

Operating cash flow-$17.9M+37.7%

CapEx$51.0K+104%

Free cash flow-$17.9M+37.6%

Valuation

See full

Market cap$8.15B-14.3%

Enterprise value$8.46B-11.1%

P/E17.6×-225×

P/S11.6×-13.0×

Profitability

See full

Gross margin83.1%-4.4pp

Operating margin21.3%+5.9pp

Net margin66%+55.8pp

FCF margin-6,328.4%+4,773pp

Returns & leverage

See full

Return on equity112.6%+92.9pp

Debt / equity1.3×+0.2×

Current ratio5.8×+1.8×

Where this comes from

Reported directly by TG Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities.

The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TG Therapeutics's investment proceeds?: TG Therapeutics (TGTX) reported investment proceeds of $11.25M in Q1 2026.
How has TG Therapeutics's investment proceeds changed year-over-year?: TG Therapeutics's investment proceeds decreased by 86.0% year-over-year, from $80.4M to $11.25M.
What is the long-term trend for TG Therapeutics's investment proceeds?: Over 3 years (2021 to 2025), TG Therapeutics's investment proceeds has grown at a 62.3% compound annual growth rate (CAGR), from $55.6M to $237.5M.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.